| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sangamo Therapeutics, Inc (SGMO) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. SGMO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $331.6K | - | |
| Other | 696.7K | $121.9K | - | |
| VP | 647.4K | $113.3K | - | |
| VP | 328.7K | $57.5K | - | |
| Other | 235.3K | $41.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | Herberts Curt A. III | Senior VP &Cbo | Sell | 2,000 | $6.80 | $13,600.00 | -5.4% | |
| May 12, 2017 | Herberts Curt A. III | Senior VP &Cbo | Sell | 2,639 | $8.02 | $21,153.50 | -3.3% | |
| Jul 15, 2015 | Lanphier Edward O II | President &CEO | Sale+OE | 25,000 | $10.43 | $260,770.00 | -9.6% | |
| Jul 13, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 12,000 | $10.00 | $120,000.00 | -2.0% | |
| Jun 15, 2015 | Lanphier Edward O II | President &CEO | Sale+OE | 25,000 | $11.08 | $277,077.50 | -9.6% | |
| Jun 10, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 12,000 | $12.21 | $146,558.40 | -2.9% | |
| Jun 5, 2015 | Ando Dale G | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $12.29 | $184,393.50 | -13.4% | |
| Jun 3, 2015 | Ringo William R | Director | Sale+OE | 2,200 | $12.44 | $27,364.26 | -73.3% | |
| Jun 1, 2015 | Gregory Philip D | SVP Of Research &CSO | Sale+OE | 15,000 | $12.39 | $185,815.50 | -11.4% | |
| May 15, 2015 | Lanphier Edward O II | President &CEO | Sale+OE | 25,000 | $11.51 | $287,862.50 | -9.6% |